REGENXBIO Inc.

REGENXBIO Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. REGENXBIO Inc. is not a good value stock. REGENXBIO Inc. is not a good growth stock. REGENXBIO Inc. is not very popular among insiders. REGENXBIO Inc. is a mediocre stock to choose.
Log in to see more information.
REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and...
RGNX Fundamental Data by TradingView

News

Does REGENXBIO (NASDAQ:RGNX) Have A Healthy Balance Sheet?
Does REGENXBIO (NASDAQ:RGNX) Have A Healthy Balance Sheet?

Simply Wall St Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...\n more…

REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic Effect
REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic Effect

PR Newswire REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic Effect REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating...\n more…

REGENXBIO to Participate in Upcoming Investor Conferences
REGENXBIO to Participate in Upcoming Investor Conferences

PR Newswire REGENXBIO to Participate in Upcoming Investor Conferences REGENXBIO to Participate in Upcoming Investor Conferences PR Newswire ROCKVILLE, Md., Aug. 29, 2024 ROCKVILLE, Md., Aug. 29, 2024...\n more…

Former RegenxBio execs launch startup with $15M and key licensing deal
Former RegenxBio execs launch startup with $15M and key licensing deal

Bizjournals.com - Health Care News Three former RegenxBio executives have launched a new company with millions of dollars in funding - and a key licensing deal with their former employer.\n more…

REGENXBIO Announces Presentation at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium
REGENXBIO Announces Presentation at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium

PR Newswire REGENXBIO Announces Presentation at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium REGENXBIO Announces Presentation at the Society for the Study of Inborn...\n more…

REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

PR Newswire REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference PR Newswire...\n more…